Co-Diagnostics Begins Clinical Testing for Respiratory Multiplex PCR Test
The company aims to support FDA 510(k) clearance submission for its point-of-care platform detecting flu A/B, COVID-19, and RSV.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
